April 05, 2014
MD Anderson experts share updates at AACR Annual Meeting
BY Scott Merville
The 54th annual meeting of the American Association for Cancer Research opens this morning in San Diego with educational sessions and workshops that cover issues ranging from cancer immunotherapy to clinical trial design to targeted therapy to clinical cancer genetics. And how to use Twitter to enhance and advance one's career.
The meeting April 5-9 will bring together about 18,000 cancer researchers, physicians, patient advocates and others from around the world to compare notes and learn the latest in preclinical, translational and early phase clinical research.
Sixteen MD Anderson scientists and physicians are chairing sessions and presenting state-of-the-art updates Saturday.
MD Anderson presentations (times, dates and place on the links):
Nicholas Navin, Ph.D., assistant professor of genetics, chairs a session titled Evolving Tumor Cell Populations: Dealth with Diversity and also will present Cancer evolution at single-cell genomic resolution.
Stephanie Alexander, program director, Genitourinary Medical Oncology -- Research, will present Intravital microscopy of tumor invasion and therapy resistance at a methods workshop titled Intravital Imaging of Live Tumors at Single Cell Resolution in Real Time.
Cassian Yee, M.D., professor of Melanoma Medical Oncology, will present Adoptive T cell therapy during an educational session about cancer immunology for the non-immunologist.
Jim Allison, Ph.D., chair and professor of Immunology, presents Immune checkpoint blockade as part of the same session.
Marina Konopleva, M.D., Ph.D., associate professor of Leukemia, chairs an educational session titled Novel Strategies for Targeting the Kinome in Leukemia and also will present Targeting kinome in leukemia: Becoming clinical reality.
David Hong, M.D., associate professor of Investigational Cancer Therapeutics, will discuss Why so many drug failures in cancer drug development during a clinical trials workshop titled Insights in the Era of Personalized Cancer Therapy and Targeted Therapies.
Padmanee Sharma, M.D., Ph.D., associate professor of Genitourinary Medical Oncology, will present Checkpoint blockade in the clinic during an educational session titled Novel Approaches to Re-Awakening the Immune System.
Louise Strong, Ph.D., professor of Genetics, will chair a session titled Clinical Cancer Genetics in the Next Generation Sequencing Era
Lee Ellis, M.D., Ph.D., professor of Surgical Oncology, will chair a methods workshop titled Insights in the Era of Personalized Therapy and Targeted Therapies: Definitive Advanced Stage Clinical Trials. He also will present Where do we set the bar for phase III trials in the current era?
Raghu Kalluri,Ph.D., professor and chair of Cancer Biology, will discuss Functional role of fibroblasts and fibrosis in cancer progression and metastasis during a session on Phenotyping and Function of Solid Tumor Stroma.
Ester Borras, Ph.D., postdoctoral fellow, and Eduardo Vilar, M.D., Ph.D., assistant professor of Clinical Cancer Prevention and Y. Nancy You, M.D., assistant professor of Surgical Oncology will present Molecular targets and chemoprevention drug development in hereditary colorectal cancer syndromes during the session Early Intervention in Genetically Identified High-Risk Individuals.
Kalluri also will serve as roundtable mentor for a professional advancement session -- the 17th Annual Grant Writing Workshop, organized by the Associate Member Council.
Naoto Ueno, M.D., Ph.D., professor of Breast Medical Oncology, will discuss Using Twitter to engage your audiences during an evening seminar on social media for scientists.